Key points A 69-year-old man presented to the emergency department with several months of progressive weakness, exertional dyspnea, and recurrent sinopulmonary infections. Over the preceding 6 months, ...

Learn to lessen the anxiety associated with SCIg for primary immunodeficiency. Get effective tips for both adults and children, including training, relaxation, and support techniques.

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing reactions, recordkeeping, and when to seek help.

Specific antibody deficiency (SAD) is an immune system disorder. It occurs when you have normal levels of antibodies but an insufficient immune response to certain types of bacteria. Antibodies, also ...

Dr. Brooke A. Rice (Medicine): A 56-year-old man was admitted to this hospital because of left lower abdominal pain and anemia. The patient had been in his usual state of health until 1 year before ...

Migliavacca M, Barzaghi F, Fossati C, et al. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. Nat Med 2024;30:488-497.

Like their causative mutations, pathophysiology and natural history, the clinical presentation of inborn errors of immunity (IEI) varies widely. Nevertheless, some features, above all recurrent and/or ...

Objective: Patients with selective IgA deficiency (SIgAD) present elevated morbidity associated with infections, allergic conditions, autoimmune disorders, and neoplasms. This study aims to ...

Primary immunodeficiency (PI) not only increases your risk of frequent and serious infections, but can also make you more likely to develop autoimmune diseases — conditions where the immune system ...

I maintain my buy rating on iShares Expanded Tech Sector ETF, expecting strong returns as tech stocks benefit from robust earnings, AI demand, and favorable macro conditions. IGM’s diversified ...

Concentra Biosciences continues to scavenge for struggling biotechs, this time picking up antibody biotech IGM Biosciences for $1.25 per share. IGM’s board has approved the acquisition by Tang Capital ...